Mallinckrodt reaches $35 million settlement in U.S. drug probe

(Reuters) - Mallinckrodt Plc, a manufacturer of the generic painkiller oxycodone, said on Monday it had reached a $35 million settlement to resolve U.S. probes into its monitoring and reporting of suspicious orders of controlled substances.